About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Hormone Therapy for Migraine Offers No Risk of Heart Disease
Advertisement

Hormone Therapy for Migraine Offers No Risk of Heart Disease

Font : A-A+

Highlights:
  • Hormone therapy does not increase the risk of heart disease.
  • It helps in treating menopause symptoms.
  • It also helps in prevention of bone loss.

Migraine headaches are common among women, but due to various health risks can be challenging to treat in the elderly. While hormone therapy is effective in relieving many menopause symptoms, its safe use in women with migraines was unconfirmed. A new study based on data from the Women's Health Initiative (WHI) demonstrates its safety for this population.

Menopause, Migraine, and Hormone Therapy
"Hormone therapy use has been on the decline since the WHI clinical trials. Newer data has brought further clarity to its safe use, especially in younger women (age < 60) who are closer to the time of menopause (within 10 years of menopause)," says Dr. Peter F. Schnatz, immediate past president of NAMS and one of the study's authors. "Based on this newer data, hormones still have a major role in treating menopause symptoms and preventing bone loss. A number of these women will have migraines. Hence, knowing the risk/benefit profile of hormone therapy in these women is critically important."

Advertisement


There have been few studies demonstrating the effect of hormone therapy on migraines and subsequent cardiovascular disease. Hormones have often not been prescribed for migraine sufferers because of the association between exogenous estrogen use and an increased risk of stroke in women who have migraines. This led to the recommendation that combined oral contraceptives (better known as birth control pills) should be used cautiously or avoided entirely in women with a history of migraines, depending on whether or not the migraines were accompanied by an aura.

Migraine and Cardiovascular Diseases
Data for 67,903 participants of the WHI clinical trials were analyzed to further examine the relationship between migraines and cardiovascular disease events and their interaction with hormone therapy use. It was discovered that women with migraines tended to drink and exercise less than those without migraines and had higher vitamin D and calcium intake. Migraine sufferers were also more likely to have night sweats and hot flashes. Importantly, researchers did not detect a significant risk of cardiovascular disease events associated with a history of migraines. Most significantly, from the treatment safety perspective, there was no impact from hormone therapy on this relationship.
Advertisement

"Since migraines affect one in every four women and women with migraines are often advised to avoid hormone therapy, these findings may have significant public health implications," says Dr. Jelena Pavlovic, lead author of the study from Albert Einstein College of Medicine in the Bronx.

"We know that changes in estrogen lead to migraines for many women. Yet, there has been very little research focused on migraines through the menopause transition when estrogen levels can fluctuate greatly," says Dr. JoAnn Pinkerton, NAMS executive director. "This study clearly demonstrates the need for more research in this area so symptomatic women can benefit from proven therapies."

References :
  1. Pavlovic et al, Please Don't Give Hormone Therapy a D Recommendation or State That "Harms Far Outweigh Benefits For Prevention Of Chronic Disease" The Journal of the North American Menopause Societyhttp:journals.lww.com/menopausejournal/Citation/2017/10000/Please_don_t_give_hormone_therapy_a_D.1.aspx


Source: Eurekalert

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chrisy Ngilneii. (2017, October 12). Hormone Therapy for Migraine Offers No Risk of Heart Disease. Medindia. Retrieved on May 20, 2022 from https://www.medindia.net/news/healthwatch/hormone-therapy-for-migraine-offers-no-risk-of-heart-disease-173720-1.htm.

  • MLA

    Chrisy Ngilneii. "Hormone Therapy for Migraine Offers No Risk of Heart Disease". Medindia. May 20, 2022. <https://www.medindia.net/news/healthwatch/hormone-therapy-for-migraine-offers-no-risk-of-heart-disease-173720-1.htm>.

  • Chicago

    Chrisy Ngilneii. "Hormone Therapy for Migraine Offers No Risk of Heart Disease". Medindia. https://www.medindia.net/news/healthwatch/hormone-therapy-for-migraine-offers-no-risk-of-heart-disease-173720-1.htm. (accessed May 20, 2022).

  • Harvard

    Chrisy Ngilneii. 2021. Hormone Therapy for Migraine Offers No Risk of Heart Disease. Medindia, viewed May 20, 2022, https://www.medindia.net/news/healthwatch/hormone-therapy-for-migraine-offers-no-risk-of-heart-disease-173720-1.htm.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Prevent Hacking of Medical Devices: FDA Sounds Alarm
Black Water: Benefits and Uses
World Hypertension Day 2022 - Measure Blood Pressure Accurately, Control It, Live Longer!
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Migraine Cardiac Catheterization Heart Attack Air travel: To fly or not to fly Diet Lifestyle and Heart Disease Body Mass Index Reiki and Pranic Healing Silent Killer Diseases Headache / Cephalgia Heart 

Most Popular on Medindia

Color Blindness Calculator Daily Calorie Requirements Find a Doctor Hearing Loss Calculator The Essence of Yoga Drug Interaction Checker Blood Pressure Calculator Post-Nasal Drip Sinopril (2mg) (Lacidipine) Vent Forte (Theophylline)

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use